N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation

Published:2003-08 Issue:4 Volume:32 Page:349-354
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Sjöö F,Aschan J,Barkholt L,Hassan Z,Ringdén O,Hassan M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704143.pdf

Reference35 articles.

1. Fried W, Kede A, Barone J . Effects of cyclophosphamide and busulfan on spleen-colony-forming units and on hematopoietic stroma. Cancer Res 1977; 37: 1205.

2. Elson LA . Hematological effects of the alkylating agents. Ann NY Acad Sci 1958; 68: 826.

3. Santos WG, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347–1353.

4. Tutschka PJ, Copelan EA, Klein JP . Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382–1388.

5. Ringdén O, Ruutu T, Remberger M et al. A randomised trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplant Group. Blood 1994; 83: 2723–2730.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols;Transplantation and Cellular Therapy;2024-07

2. Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience;Pharmaceutics;2023-12-20

3. Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial;BMC Medicine;2022-04-27

4. Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review;FARM HOSP;2021

5. Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients;Clinical Pharmacokinetics;2020-10-30